protein

Recombinant Human c-Abl His-tag Protein, CF

11091-AL-020

20 ug

354 USD

11091-AL-020

Recombinant Human c-Abl His-tag Protein, CF

20 ug

The Recombinant Human c-Abl His-tag Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human c-Abl His-tag Protein, CF has been validated for the following applications: Enzyme Activity.

c-Abl

Proteins and Enzymes

Supplied as a 0.2 ╡m filtered solution in Tris, NaCl, TCEP and Glycerol.

Unconjugated

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Human

33-35 kDa, under reducing conditions

34 kDa

Measured by its ability to phosphorylate the Abl peptide substrate EAIYAAPFAKKK. The specific activity is 200 pmol/min/╡g, as measured under the described conditions.

<1.0 EU per 1 ╡g of the protein by the LAL method.

P00519.4

Enzyme Activity

E. coli -derived human c-Abl protein Gly227-Gln513, with an N-terminal Met and 6-His tag

E. coli

354 USD

Abelson murine leukemia viral oncogene homolog 1, ABL, ABL1, bcr/abl, BCR-ABL1, cAbl, c-ABL, c-abl oncogene 1, non-receptor tyrosine kinase, c-abl oncogene 1, receptor tyrosine kinase, EC 2.7.10, EC 2.7.10.2, JTK7, JTK7bcr/abl, p150bcr/c-abl oncogene protein, Proto-oncogene c-Abl, proto-oncogene tyrosine-protein kinase ABL1, tyrosine-protein kinase ABL1, v-abl, v-abl Abelson murine leukemia viral oncogene homolog 1

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 ░C as supplied. 3 months, -20 to -70 ░C under sterile conditions after opening.